Filing Details

Accession Number:
0001437749-21-014193
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-04 20:25:24
Reporting Period:
2021-06-02
Accepted Time:
2021-06-04 20:25:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213809 Dyadic International Inc DYAI Biological Products, (No Disgnostic Substances) (2836) 450486747
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1328287 A Mark Emalfarb C/o Dyadic International, Inc.
140 Intracoastal Pointe Drive Suite 404
Jupiter FL 33477-5094
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-02 76,349 $3.74 4,090,638 No 4 S Indirect Through Mark A. Emalfarb Trust U/A DTD 10/1/1987
Common Stock Disposition 2021-06-03 26,721 $3.61 4,063,917 No 4 S Indirect Through Mark A Emalfarb Trust U/A DTD 10/1/1987
Common Stock Disposition 2021-06-04 132,000 $3.85 3,931,917 No 4 S Indirect Through Mark A Emalfarb Trust U/A/ DTD 10/1/1987
Common Stock Acquisiton 2021-06-04 400,000 $1.67 4,331,917 No 4 M Indirect Through Mark A. Emalfarb Trust U/A DTD 10/1/1987
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Through Mark A. Emalfarb Trust U/A DTD 10/1/1987
No 4 S Indirect Through Mark A Emalfarb Trust U/A DTD 10/1/1987
No 4 S Indirect Through Mark A Emalfarb Trust U/A/ DTD 10/1/1987
No 4 M Indirect Through Mark A. Emalfarb Trust U/A DTD 10/1/1987
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-06-04 400,000 $0.00 400,000 $1.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-06-21 2021-06-21 No 4 M Direct
Footnotes
  1. These shares were sold to satisfy exercise price and tax withholding obligations to be funded for options expiring on June 21, 2021. As a result of the option exercises and sale transactions reported on this Form 4, the reporting person's net share ownership increased by 164,930 shares, from 4,166,987 to 4,331,917 shares of Common Stock.
  2. The price reported in Column 4 is a weighted average price. These sold in multiple transactions at prices ranging from $3.82 to $3.65, inclusive, on June 2, 2021, $3.70 to $3.60, inclusive, on June 3, 2021, and $4.00 to $3.70, inclusive, on June 4, 2021. The reporting person undertakes to provide to Dyadic International, Inc., any security holder of Dyadic International, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of footnote (2) to this Form 4.
  3. Exercise of reporting person's stock options that would otherwise expire June 21, 2021.